logo

PASG

Passage Bio·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural

Passage Bio's fundamentals score 5.8/10, indicating mixed quality. Strengths lie in its PB-ROE (5.6753) and Asset-MV (-0.5007) values, which rank in higher-performing quartiles, while concerns emerge from Net profit / Total profit (%) at 100% and Revenue-MV (-0.2574), placing them in less favorable groups. This combination supports a selective investment view rather than an outright recommendation.

Fundamental(5.75)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.26
Score1/3
Weight9.19%
1M Return5.20%
Inventory turnover ratio
Value47.85
Score3/3
Weight8.07%
1M Return5.26%
Gross profit margin (%)
Value36.70
Score1/3
Weight-0.71%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight13.76%
1M Return7.79%
PB-ROE
Value5.68
Score3/3
Weight21.61%
1M Return11.47%
Current assets turnover ratio
Value1.78
Score2/3
Weight1.61%
1M Return1.15%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight1.17%
1M Return0.86%
Asset-MV
Value-0.50
Score3/3
Weight31.93%
1M Return14.99%
Cash-MV
Value-0.07
Score2/3
Weight13.78%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.41%
1M Return-0.30%
Is PASG fundamentally strong?
  • PASG scores 5.75/10 on fundamentals and holds a Fair valuation at present. Backed by its -70.45% ROE, 0.00% net margin, -0.67 P/E ratio, 0.97 P/B ratio, and 36.55% earnings growth, these metrics solidify its Netural investment rating.